Complement factor D in age-related macular degeneration

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 12, 2011, Pages 8828-8834

  Stanton, Chloe M ^a   Yates, John R W ^b   den Hollander, Anneke I ^c   Seddon, Johanna M ^d   Swaroop, Anand ^e   Stambolian, Dwight ^f   Fauser, Sascha ^g   Hoyng, Carel ^c   Yu, Yi ^d   Atsuhiro, Kanda ^e   Branham, Kari ^h   Othman, Mohammad ^h   Chen, Wei ⁱ   Kortvely, Elod ^j   Chalmers, Kevin ^a   Hayward, Caroline ^a   Moore, Anthony T ^b   Dhillon, Baljean ^k   Ueffing, Marius ^j   Wright, Alan F ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d TUFTS MEDICAL CENTER   (United States)

^e NATIONAL EYE INSTITUTE   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^h UNIVERSITY OF MICHIGAN   (United States)

ⁱ UNIVERSITY OF MICHIGAN   (United States)

^j Institute for Ophthalmic Research   (Germany)

^k UNIVERSITY OF EDINBURGH   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR D; COMPLEMENT FACTOR D, HUMAN;

AGED; ARTICLE; CFD GENE; CONTROLLED STUDY; COPY NUMBER VARIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENE DOSAGE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; COHORT ANALYSIS; COMPLEMENT ALTERNATIVE PATHWAY; GENETICS; META ANALYSIS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; RETINA MACULA DEGENERATION;

AGED; AGED, 80 AND OVER; COHORT STUDIES; COMPLEMENT FACTOR D; COMPLEMENT PATHWAY, ALTERNATIVE; FEMALE; GENE DOSAGE; GENOTYPE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84855412592     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-7933     Document Type: Article

References (32)

1. Volanakis JE, Narayana SV. Complement factor D, a novel serine protease. Protein Sci. 1996;5:553-564.
2. Xu Y, Narayana SV, Volanakis JE. Structural biology of the alternative pathway convertase. Immunol Rev. 2001;180:123-135.
3. Cook KS, Groves DL, Min HY, Spiegelman BM. A developmentally regulated mRNA from 3T3 adipocytes encodes a novel serine protease homologue. Proc Natl Acad Sci U S A. 1985;82:6480-6484.
4. White RT, Damm D, Hancock N, et al. Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. J Biol Chem. 1992;267:9210-9213.
5. Gabrielsson BG, Johansson JM, Lönn M, et al. High expression of complement components in omental adipose tissue in obese men. Obes Res. 2003;11:699-708.
6. Whaley K. Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes. J Exp Med. 1980;151:501-516.
7. Barnum SR, Volanakis JE. In vitro biosynthesis of complement protein D by U937 cells. J Immunol. 1985;134:1799-1803.
8. Jing H, Macon KJ, Moore D, DeLucas LJ, Volanakis JE, Narayana SV. Structural basis of profactor D activation: from a highly flexible zymogen to a novel self-inhibited serine protease, complement factor D. Embo J. 1999;18:804-814.
9. Fearon DT, Austen KF, Ruddy S. Properdin factor D: characterization of its active site and isolation of the precursor form. J Exp Med. 1974;139:355-366.
10. Yamauchi Y, Stevens JW, Macon KJ, Volanakis JE. Recombinant and native zymogen forms of human complement factor D. J Immunol. 1994;152:3645-3653.
11. Lesavre PH, Muller-Eberhard HJ. Mechanism of action of factor D of the alternative complement pathway. J Exp Med. 1978;148: 1498-1509.
12. Barnum SR, Niemann MA, Kearney JF, Volanakis JE. Quantitation of complement factor D in human serum by a solid-phase radioimmunoassay. J Immunol Methods. 1984;67:303-309.
13. Schreiber RD, Muller-Eberhard HJ. Assembly of the cytolytic alternative pathway of complement from 11 isolated plasma proteins. J Exp Med. 1978;148:1722-1727.
14. Bunce C, Xing W, Wormald R. Causes of blind and partial sight certifications in England and Wales: April 2007-March 2008. Eye (Lond) 2010;24:1692-1699.
15. Jager RD, Mieler WF, Miller JW. Age-related macular degeneration. N Engl J Med. 2008;358:2606-2617.
16. Montezuma SR, Sobrin L, Seddon JM. Review of genetics in age related macular degeneration. Semin Ophthalmol. 2007;22:229-240.
17. Evans JR. Risk factors for age-related macular degeneration. Prog Retin Eye Res. 2001;20:227-253.
18. Swaroop A, Branham KE, Chen W, Abecasis G. Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits. Hum Mol Genet. 2007;16 Spec No 2:R174-R182.
19. Neale BM, Fagerness J, Reynolds R, et al. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci U S A. 2010;107:7395-7400.
20. Chen W, Stambolian D, Edwards AO, et al. Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A. 2010;107:7401-7406.
21. Yu Y, Reynolds R, Fagerness J, Rosner B, Daly MJ, Seddon JM. Association of variants in LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011;52:4663-4670.
22. Pascual M, Steiger G, Estreicher J, Macon K, Volanakis JE, Schifferli JA. Metabolism of complement factor D in renal failure. Kidney Int. 1988;34:529-536.
23. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol. 2005;115:911-919.
24. Miner JL. The adipocyte as an endocrine cell. J Anim Sci. 2004; 82:935-941.
25. Morgan BP, Gasque P. Extrahepatic complement biosynthesis: where, when and why? Clin Exp Immunol. 1997;107:1-7.
26. Choy LN, Rosen BS, Spiegelman BM. Adipsin and an endogenous pathway of complement from adipose cells. J Biol Chem. 1992; 267:12736-12741.
27. Peake PW, O'Grady S, Pussell BA, Charlesworth JA. Detection and quantification of the control proteins of the alternative pathway of complement in 3T3-L1 adipocytes. Eur J Clin Invest. 1997;27: 922-927.
28. Scholl HP, Charbel Issa P, Walier M, et al. Systemic complement activation in age-related macular degeneration. PLoS One. 2008;3: e2593.
29. Reynolds R, Hartnett ME, Atkinson JP, Giclas PC, Rosner B, Seddon JM. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Invest Ophthalmol Vis Sci. 2009;50:5818-5827.
30. Anderson DH, Radeke MJ, Gallo NB, et al. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res. 2010;29: 95-112.
31. Walport MJ. Complement. First of two parts. N Engl J Med. 2001; 344:1058-1066.
32. Weiss LA, Pan L, Abney M, Ober C. The sex-specific genetic architecture of quantitative traits in humans. Nat Genet. 2006;38: 218-222.